0
Skip to Content
GripRoom
Politics
Finance
ChatGPT
How To
Fun Stuff
Everything
GripRoom
Politics
Finance
ChatGPT
How To
Fun Stuff
Everything
Politics
Finance
ChatGPT
How To
Fun Stuff
Everything
BioNTech's Hesitance and Matinas BioPharma's Persistence: A Study in Risk Tolerance
David Stone 5/11/23 David Stone 5/11/23

BioNTech's Hesitance and Matinas BioPharma's Persistence: A Study in Risk Tolerance

Read More
Trojan Horse Drug Delivery: The Future of Medicine and Matinas BioPharma's LNC Technology
Isha Tanaka 5/2/23 Isha Tanaka 5/2/23

Trojan Horse Drug Delivery: The Future of Medicine and Matinas BioPharma's LNC Technology

Read More
The Potential of Matinas BioPharma’s Lipid Nano-Crystal Technology in Drug Development
Mark Armstrong 5/1/23 Mark Armstrong 5/1/23

The Potential of Matinas BioPharma’s Lipid Nano-Crystal Technology in Drug Development

Read More
Is BioNTech About to Take a Major Stake in Matinas BioPharma?
David Stone 4/24/23 David Stone 4/24/23

Is BioNTech About to Take a Major Stake in Matinas BioPharma?

Read More
Could the Next Pandemic Be Fungal-Based?
Mark Armstrong 4/20/23 Mark Armstrong 4/20/23

Could the Next Pandemic Be Fungal-Based?

Read More
Matinas BioPharma - Insightful social media posts and due diligence
GripRoom Research 4/23/22 GripRoom Research 4/23/22

Matinas BioPharma - Insightful social media posts and due diligence

Read More
Growth Stocks are Back on the Menu as Fears of WW3 Fade
David Stone 3/19/22 David Stone 3/19/22

Growth Stocks are Back on the Menu as Fears of WW3 Fade

Read More

About GripRoom Privacy Policy

Disclaimer: Nothing on this website is medical, legal, investment, or any other type of serious advice. This website is for entertainment purposes only. Always consult a professional before making an important decision.